Global Biosimilar Market Research Report 2023(Status and Outlook)
Report Overview
A product is termed as biosimilar product, if it is a biological product with similar characteristics as that of a reference biological product, which possesses approval from agencies such as FDA. There would not be any major clinical difference in effectiveness and safety as that of reference product. Biosimilar products are made of complex molecules with high molecular weight produced through genetic engineering in living cells. Biologics drugs are costlier than respective chemical drugs. Biosimilar drugs can save around 30 to 40 % in terms of price relative to the respective biologics drugs. Biosimilars are useful for the treatment of illnesses such as anemia, autoimmune diseases, cancer, diabetes, growth hormone deficiencies, hematological diseases, kidney failure, rheumatoid arthritis and others. For the manufacturing of biosimilars, manufacturers have to develop environments that are ideal for the living cells, which remain sensitive to environmental conditions. Moreover, they need to develop distinctive process to entice the living cells for producing similar outcome to a prevalent biological treatment. The substitution of biological drugs with biosimilar drugs can save lot of money for public health care sector and patients. The regulatory authorities in developed nations are promoting biosimilar products.
Bosson Research’s latest report provides a deep insight into the global Biosimilar market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Biosimilar Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Biosimilar market in any manner.
Global Biosimilar Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Allergan plc
BIOCAD
Biocon
BioXpress Therapeutics
Boehringer Ingelheim
Celltrion
Coherus BioSciences
Dr. Reddy’s Laboratories
Genor BioPharma
Intas Pharmaceuticals Limited
Novartis
Pfizer
Market Segmentation (by Type)
Human Growth Hormones
Monoclonal Antibodies
Insulin
Peptides
Erythropoietin
Others
Market Segmentation (by Application)
Oncology
Chronic and Autoimmune Diseases
Growth Hormone Deficiency
Infectious Diseases
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Biosimilar Market
Overview of the regional outlook of the Biosimilar Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value (USD Billion) data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Biosimilar Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
A product is termed as biosimilar product, if it is a biological product with similar characteristics as that of a reference biological product, which possesses approval from agencies such as FDA. There would not be any major clinical difference in effectiveness and safety as that of reference product. Biosimilar products are made of complex molecules with high molecular weight produced through genetic engineering in living cells. Biologics drugs are costlier than respective chemical drugs. Biosimilar drugs can save around 30 to 40 % in terms of price relative to the respective biologics drugs. Biosimilars are useful for the treatment of illnesses such as anemia, autoimmune diseases, cancer, diabetes, growth hormone deficiencies, hematological diseases, kidney failure, rheumatoid arthritis and others. For the manufacturing of biosimilars, manufacturers have to develop environments that are ideal for the living cells, which remain sensitive to environmental conditions. Moreover, they need to develop distinctive process to entice the living cells for producing similar outcome to a prevalent biological treatment. The substitution of biological drugs with biosimilar drugs can save lot of money for public health care sector and patients. The regulatory authorities in developed nations are promoting biosimilar products.
Bosson Research’s latest report provides a deep insight into the global Biosimilar market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Biosimilar Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Biosimilar market in any manner.
Global Biosimilar Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Allergan plc
BIOCAD
Biocon
BioXpress Therapeutics
Boehringer Ingelheim
Celltrion
Coherus BioSciences
Dr. Reddy’s Laboratories
Genor BioPharma
Intas Pharmaceuticals Limited
Novartis
Pfizer
Market Segmentation (by Type)
Human Growth Hormones
Monoclonal Antibodies
Insulin
Peptides
Erythropoietin
Others
Market Segmentation (by Application)
Oncology
Chronic and Autoimmune Diseases
Growth Hormone Deficiency
Infectious Diseases
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Biosimilar Market
Overview of the regional outlook of the Biosimilar Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value (USD Billion) data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Biosimilar Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Biosimilar
1.2 Key Market Segments
1.2.1 Biosimilar Segment by Type
1.2.2 Biosimilar Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 BIOSIMILAR MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Biosimilar Market Size (M USD) Estimates and Forecasts (2018-2029)
2.1.2 Global Biosimilar Sales Estimates and Forecasts (2018-2029)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 BIOSIMILAR MARKET COMPETITIVE LANDSCAPE
3.1 Global Biosimilar Sales by Manufacturers (2018-2023)
3.2 Global Biosimilar Revenue Market Share by Manufacturers (2018-2023)
3.3 Biosimilar Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Biosimilar Average Price by Manufacturers (2018-2023)
3.5 Manufacturers Biosimilar Sales Sites, Area Served, Product Type
3.6 Biosimilar Market Competitive Situation and Trends
3.6.1 Biosimilar Market Concentration Rate
3.6.2 Global 5 and 10 Largest Biosimilar Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 BIOSIMILAR INDUSTRY CHAIN ANALYSIS
4.1 Biosimilar Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF BIOSIMILAR MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 BIOSIMILAR MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Biosimilar Sales Market Share by Type (2018-2023)
6.3 Global Biosimilar Market Size Market Share by Type (2018-2023)
6.4 Global Biosimilar Price by Type (2018-2023)
7 BIOSIMILAR MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Biosimilar Market Sales by Application (2018-2023)
7.3 Global Biosimilar Market Size (M USD) by Application (2018-2023)
7.4 Global Biosimilar Sales Growth Rate by Application (2018-2023)
8 BIOSIMILAR MARKET SEGMENTATION BY REGION
8.1 Global Biosimilar Sales by Region
8.1.1 Global Biosimilar Sales by Region
8.1.2 Global Biosimilar Sales Market Share by Region
8.2 North America
8.2.1 North America Biosimilar Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Biosimilar Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Biosimilar Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Biosimilar Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Biosimilar Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Allergan plc
9.1.1 Allergan plc Biosimilar Basic Information
9.1.2 Allergan plc Biosimilar Product Overview
9.1.3 Allergan plc Biosimilar Product Market Performance
9.1.4 Allergan plc Business Overview
9.1.5 Allergan plc Biosimilar SWOT Analysis
9.1.6 Allergan plc Recent Developments
9.2 BIOCAD
9.2.1 BIOCAD Biosimilar Basic Information
9.2.2 BIOCAD Biosimilar Product Overview
9.2.3 BIOCAD Biosimilar Product Market Performance
9.2.4 BIOCAD Business Overview
9.2.5 BIOCAD Biosimilar SWOT Analysis
9.2.6 BIOCAD Recent Developments
9.3 Biocon
9.3.1 Biocon Biosimilar Basic Information
9.3.2 Biocon Biosimilar Product Overview
9.3.3 Biocon Biosimilar Product Market Performance
9.3.4 Biocon Business Overview
9.3.5 Biocon Biosimilar SWOT Analysis
9.3.6 Biocon Recent Developments
9.4 BioXpress Therapeutics
9.4.1 BioXpress Therapeutics Biosimilar Basic Information
9.4.2 BioXpress Therapeutics Biosimilar Product Overview
9.4.3 BioXpress Therapeutics Biosimilar Product Market Performance
9.4.4 BioXpress Therapeutics Business Overview
9.4.5 BioXpress Therapeutics Biosimilar SWOT Analysis
9.4.6 BioXpress Therapeutics Recent Developments
9.5 Boehringer Ingelheim
9.5.1 Boehringer Ingelheim Biosimilar Basic Information
9.5.2 Boehringer Ingelheim Biosimilar Product Overview
9.5.3 Boehringer Ingelheim Biosimilar Product Market Performance
9.5.4 Boehringer Ingelheim Business Overview
9.5.5 Boehringer Ingelheim Biosimilar SWOT Analysis
9.5.6 Boehringer Ingelheim Recent Developments
9.6 Celltrion
9.6.1 Celltrion Biosimilar Basic Information
9.6.2 Celltrion Biosimilar Product Overview
9.6.3 Celltrion Biosimilar Product Market Performance
9.6.4 Celltrion Business Overview
9.6.5 Celltrion Recent Developments
9.7 Coherus BioSciences
9.7.1 Coherus BioSciences Biosimilar Basic Information
9.7.2 Coherus BioSciences Biosimilar Product Overview
9.7.3 Coherus BioSciences Biosimilar Product Market Performance
9.7.4 Coherus BioSciences Business Overview
9.7.5 Coherus BioSciences Recent Developments
9.8 Dr. Reddy’s Laboratories
9.8.1 Dr. Reddy’s Laboratories Biosimilar Basic Information
9.8.2 Dr. Reddy’s Laboratories Biosimilar Product Overview
9.8.3 Dr. Reddy’s Laboratories Biosimilar Product Market Performance
9.8.4 Dr. Reddy’s Laboratories Business Overview
9.8.5 Dr. Reddy’s Laboratories Recent Developments
9.9 Genor BioPharma
9.9.1 Genor BioPharma Biosimilar Basic Information
9.9.2 Genor BioPharma Biosimilar Product Overview
9.9.3 Genor BioPharma Biosimilar Product Market Performance
9.9.4 Genor BioPharma Business Overview
9.9.5 Genor BioPharma Recent Developments
9.10 Intas Pharmaceuticals Limited
9.10.1 Intas Pharmaceuticals Limited Biosimilar Basic Information
9.10.2 Intas Pharmaceuticals Limited Biosimilar Product Overview
9.10.3 Intas Pharmaceuticals Limited Biosimilar Product Market Performance
9.10.4 Intas Pharmaceuticals Limited Business Overview
9.10.5 Intas Pharmaceuticals Limited Recent Developments
9.11 Novartis
9.11.1 Novartis Biosimilar Basic Information
9.11.2 Novartis Biosimilar Product Overview
9.11.3 Novartis Biosimilar Product Market Performance
9.11.4 Novartis Business Overview
9.11.5 Novartis Recent Developments
9.12 Pfizer
9.12.1 Pfizer Biosimilar Basic Information
9.12.2 Pfizer Biosimilar Product Overview
9.12.3 Pfizer Biosimilar Product Market Performance
9.12.4 Pfizer Business Overview
9.12.5 Pfizer Recent Developments
10 BIOSIMILAR MARKET FORECAST BY REGION
10.1 Global Biosimilar Market Size Forecast
10.2 Global Biosimilar Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Biosimilar Market Size Forecast by Country
10.2.3 Asia Pacific Biosimilar Market Size Forecast by Region
10.2.4 South America Biosimilar Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Biosimilar by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2024-2029)
11.1 Global Biosimilar Market Forecast by Type (2024-2029)
11.1.1 Global Forecasted Sales of Biosimilar by Type (2024-2029)
11.1.2 Global Biosimilar Market Size Forecast by Type (2024-2029)
11.1.3 Global Forecasted Price of Biosimilar by Type (2024-2029)
11.2 Global Biosimilar Market Forecast by Application (2024-2029)
11.2.1 Global Biosimilar Sales (K MT) Forecast by Application
11.2.2 Global Biosimilar Market Size (M USD) Forecast by Application (2024-2029)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Biosimilar
1.2 Key Market Segments
1.2.1 Biosimilar Segment by Type
1.2.2 Biosimilar Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 BIOSIMILAR MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Biosimilar Market Size (M USD) Estimates and Forecasts (2018-2029)
2.1.2 Global Biosimilar Sales Estimates and Forecasts (2018-2029)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 BIOSIMILAR MARKET COMPETITIVE LANDSCAPE
3.1 Global Biosimilar Sales by Manufacturers (2018-2023)
3.2 Global Biosimilar Revenue Market Share by Manufacturers (2018-2023)
3.3 Biosimilar Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Biosimilar Average Price by Manufacturers (2018-2023)
3.5 Manufacturers Biosimilar Sales Sites, Area Served, Product Type
3.6 Biosimilar Market Competitive Situation and Trends
3.6.1 Biosimilar Market Concentration Rate
3.6.2 Global 5 and 10 Largest Biosimilar Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 BIOSIMILAR INDUSTRY CHAIN ANALYSIS
4.1 Biosimilar Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF BIOSIMILAR MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 BIOSIMILAR MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Biosimilar Sales Market Share by Type (2018-2023)
6.3 Global Biosimilar Market Size Market Share by Type (2018-2023)
6.4 Global Biosimilar Price by Type (2018-2023)
7 BIOSIMILAR MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Biosimilar Market Sales by Application (2018-2023)
7.3 Global Biosimilar Market Size (M USD) by Application (2018-2023)
7.4 Global Biosimilar Sales Growth Rate by Application (2018-2023)
8 BIOSIMILAR MARKET SEGMENTATION BY REGION
8.1 Global Biosimilar Sales by Region
8.1.1 Global Biosimilar Sales by Region
8.1.2 Global Biosimilar Sales Market Share by Region
8.2 North America
8.2.1 North America Biosimilar Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Biosimilar Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Biosimilar Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Biosimilar Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Biosimilar Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Allergan plc
9.1.1 Allergan plc Biosimilar Basic Information
9.1.2 Allergan plc Biosimilar Product Overview
9.1.3 Allergan plc Biosimilar Product Market Performance
9.1.4 Allergan plc Business Overview
9.1.5 Allergan plc Biosimilar SWOT Analysis
9.1.6 Allergan plc Recent Developments
9.2 BIOCAD
9.2.1 BIOCAD Biosimilar Basic Information
9.2.2 BIOCAD Biosimilar Product Overview
9.2.3 BIOCAD Biosimilar Product Market Performance
9.2.4 BIOCAD Business Overview
9.2.5 BIOCAD Biosimilar SWOT Analysis
9.2.6 BIOCAD Recent Developments
9.3 Biocon
9.3.1 Biocon Biosimilar Basic Information
9.3.2 Biocon Biosimilar Product Overview
9.3.3 Biocon Biosimilar Product Market Performance
9.3.4 Biocon Business Overview
9.3.5 Biocon Biosimilar SWOT Analysis
9.3.6 Biocon Recent Developments
9.4 BioXpress Therapeutics
9.4.1 BioXpress Therapeutics Biosimilar Basic Information
9.4.2 BioXpress Therapeutics Biosimilar Product Overview
9.4.3 BioXpress Therapeutics Biosimilar Product Market Performance
9.4.4 BioXpress Therapeutics Business Overview
9.4.5 BioXpress Therapeutics Biosimilar SWOT Analysis
9.4.6 BioXpress Therapeutics Recent Developments
9.5 Boehringer Ingelheim
9.5.1 Boehringer Ingelheim Biosimilar Basic Information
9.5.2 Boehringer Ingelheim Biosimilar Product Overview
9.5.3 Boehringer Ingelheim Biosimilar Product Market Performance
9.5.4 Boehringer Ingelheim Business Overview
9.5.5 Boehringer Ingelheim Biosimilar SWOT Analysis
9.5.6 Boehringer Ingelheim Recent Developments
9.6 Celltrion
9.6.1 Celltrion Biosimilar Basic Information
9.6.2 Celltrion Biosimilar Product Overview
9.6.3 Celltrion Biosimilar Product Market Performance
9.6.4 Celltrion Business Overview
9.6.5 Celltrion Recent Developments
9.7 Coherus BioSciences
9.7.1 Coherus BioSciences Biosimilar Basic Information
9.7.2 Coherus BioSciences Biosimilar Product Overview
9.7.3 Coherus BioSciences Biosimilar Product Market Performance
9.7.4 Coherus BioSciences Business Overview
9.7.5 Coherus BioSciences Recent Developments
9.8 Dr. Reddy’s Laboratories
9.8.1 Dr. Reddy’s Laboratories Biosimilar Basic Information
9.8.2 Dr. Reddy’s Laboratories Biosimilar Product Overview
9.8.3 Dr. Reddy’s Laboratories Biosimilar Product Market Performance
9.8.4 Dr. Reddy’s Laboratories Business Overview
9.8.5 Dr. Reddy’s Laboratories Recent Developments
9.9 Genor BioPharma
9.9.1 Genor BioPharma Biosimilar Basic Information
9.9.2 Genor BioPharma Biosimilar Product Overview
9.9.3 Genor BioPharma Biosimilar Product Market Performance
9.9.4 Genor BioPharma Business Overview
9.9.5 Genor BioPharma Recent Developments
9.10 Intas Pharmaceuticals Limited
9.10.1 Intas Pharmaceuticals Limited Biosimilar Basic Information
9.10.2 Intas Pharmaceuticals Limited Biosimilar Product Overview
9.10.3 Intas Pharmaceuticals Limited Biosimilar Product Market Performance
9.10.4 Intas Pharmaceuticals Limited Business Overview
9.10.5 Intas Pharmaceuticals Limited Recent Developments
9.11 Novartis
9.11.1 Novartis Biosimilar Basic Information
9.11.2 Novartis Biosimilar Product Overview
9.11.3 Novartis Biosimilar Product Market Performance
9.11.4 Novartis Business Overview
9.11.5 Novartis Recent Developments
9.12 Pfizer
9.12.1 Pfizer Biosimilar Basic Information
9.12.2 Pfizer Biosimilar Product Overview
9.12.3 Pfizer Biosimilar Product Market Performance
9.12.4 Pfizer Business Overview
9.12.5 Pfizer Recent Developments
10 BIOSIMILAR MARKET FORECAST BY REGION
10.1 Global Biosimilar Market Size Forecast
10.2 Global Biosimilar Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Biosimilar Market Size Forecast by Country
10.2.3 Asia Pacific Biosimilar Market Size Forecast by Region
10.2.4 South America Biosimilar Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Biosimilar by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2024-2029)
11.1 Global Biosimilar Market Forecast by Type (2024-2029)
11.1.1 Global Forecasted Sales of Biosimilar by Type (2024-2029)
11.1.2 Global Biosimilar Market Size Forecast by Type (2024-2029)
11.1.3 Global Forecasted Price of Biosimilar by Type (2024-2029)
11.2 Global Biosimilar Market Forecast by Application (2024-2029)
11.2.1 Global Biosimilar Sales (K MT) Forecast by Application
11.2.2 Global Biosimilar Market Size (M USD) Forecast by Application (2024-2029)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Biosimilar Market Size Comparison by Region (M USD)
Table 5. Global Biosimilar Sales (K MT) by Manufacturers (2018-2023)
Table 6. Global Biosimilar Sales Market Share by Manufacturers (2018-2023)
Table 7. Global Biosimilar Revenue (M USD) by Manufacturers (2018-2023)
Table 8. Global Biosimilar Revenue Share by Manufacturers (2018-2023)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biosimilar as of 2022)
Table 10. Global Market Biosimilar Average Price (USD/MT) of Key Manufacturers (2018-2023)
Table 11. Manufacturers Biosimilar Sales Sites and Area Served
Table 12. Manufacturers Biosimilar Product Type
Table 13. Global Biosimilar Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Biosimilar
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Biosimilar Market Challenges
Table 22. Market Restraints
Table 23. Global Biosimilar Sales by Type (K MT)
Table 24. Global Biosimilar Market Size by Type (M USD)
Table 25. Global Biosimilar Sales (K MT) by Type (2018-2023)
Table 26. Global Biosimilar Sales Market Share by Type (2018-2023)
Table 27. Global Biosimilar Market Size (M USD) by Type (2018-2023)
Table 28. Global Biosimilar Market Size Share by Type (2018-2023)
Table 29. Global Biosimilar Price (USD/MT) by Type (2018-2023)
Table 30. Global Biosimilar Sales (K MT) by Application
Table 31. Global Biosimilar Market Size by Application
Table 32. Global Biosimilar Sales by Application (2018-2023) & (K MT)
Table 33. Global Biosimilar Sales Market Share by Application (2018-2023)
Table 34. Global Biosimilar Sales by Application (2018-2023) & (M USD)
Table 35. Global Biosimilar Market Share by Application (2018-2023)
Table 36. Global Biosimilar Sales Growth Rate by Application (2018-2023)
Table 37. Global Biosimilar Sales by Region (2018-2023) & (K MT)
Table 38. Global Biosimilar Sales Market Share by Region (2018-2023)
Table 39. North America Biosimilar Sales by Country (2018-2023) & (K MT)
Table 40. Europe Biosimilar Sales by Country (2018-2023) & (K MT)
Table 41. Asia Pacific Biosimilar Sales by Region (2018-2023) & (K MT)
Table 42. South America Biosimilar Sales by Country (2018-2023) & (K MT)
Table 43. Middle East and Africa Biosimilar Sales by Region (2018-2023) & (K MT)
Table 44. Allergan plc Biosimilar Basic Information
Table 45. Allergan plc Biosimilar Product Overview
Table 46. Allergan plc Biosimilar Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 47. Allergan plc Business Overview
Table 48. Allergan plc Biosimilar SWOT Analysis
Table 49. Allergan plc Recent Developments
Table 50. BIOCAD Biosimilar Basic Information
Table 51. BIOCAD Biosimilar Product Overview
Table 52. BIOCAD Biosimilar Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 53. BIOCAD Business Overview
Table 54. BIOCAD Biosimilar SWOT Analysis
Table 55. BIOCAD Recent Developments
Table 56. Biocon Biosimilar Basic Information
Table 57. Biocon Biosimilar Product Overview
Table 58. Biocon Biosimilar Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 59. Biocon Business Overview
Table 60. Biocon Biosimilar SWOT Analysis
Table 61. Biocon Recent Developments
Table 62. BioXpress Therapeutics Biosimilar Basic Information
Table 63. BioXpress Therapeutics Biosimilar Product Overview
Table 64. BioXpress Therapeutics Biosimilar Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 65. BioXpress Therapeutics Business Overview
Table 66. BioXpress Therapeutics Biosimilar SWOT Analysis
Table 67. BioXpress Therapeutics Recent Developments
Table 68. Boehringer Ingelheim Biosimilar Basic Information
Table 69. Boehringer Ingelheim Biosimilar Product Overview
Table 70. Boehringer Ingelheim Biosimilar Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 71. Boehringer Ingelheim Business Overview
Table 72. Boehringer Ingelheim Biosimilar SWOT Analysis
Table 73. Boehringer Ingelheim Recent Developments
Table 74. Celltrion Biosimilar Basic Information
Table 75. Celltrion Biosimilar Product Overview
Table 76. Celltrion Biosimilar Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 77. Celltrion Business Overview
Table 78. Celltrion Recent Developments
Table 79. Coherus BioSciences Biosimilar Basic Information
Table 80. Coherus BioSciences Biosimilar Product Overview
Table 81. Coherus BioSciences Biosimilar Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 82. Coherus BioSciences Business Overview
Table 83. Coherus BioSciences Recent Developments
Table 84. Dr. Reddy’s Laboratories Biosimilar Basic Information
Table 85. Dr. Reddy’s Laboratories Biosimilar Product Overview
Table 86. Dr. Reddy’s Laboratories Biosimilar Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 87. Dr. Reddy’s Laboratories Business Overview
Table 88. Dr. Reddy’s Laboratories Recent Developments
Table 89. Genor BioPharma Biosimilar Basic Information
Table 90. Genor BioPharma Biosimilar Product Overview
Table 91. Genor BioPharma Biosimilar Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 92. Genor BioPharma Business Overview
Table 93. Genor BioPharma Recent Developments
Table 94. Intas Pharmaceuticals Limited Biosimilar Basic Information
Table 95. Intas Pharmaceuticals Limited Biosimilar Product Overview
Table 96. Intas Pharmaceuticals Limited Biosimilar Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 97. Intas Pharmaceuticals Limited Business Overview
Table 98. Intas Pharmaceuticals Limited Recent Developments
Table 99. Novartis Biosimilar Basic Information
Table 100. Novartis Biosimilar Product Overview
Table 101. Novartis Biosimilar Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 102. Novartis Business Overview
Table 103. Novartis Recent Developments
Table 104. Pfizer Biosimilar Basic Information
Table 105. Pfizer Biosimilar Product Overview
Table 106. Pfizer Biosimilar Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 107. Pfizer Business Overview
Table 108. Pfizer Recent Developments
Table 109. Global Biosimilar Sales Forecast by Region (2024-2029) & (K MT)
Table 110. Global Biosimilar Market Size Forecast by Region (2024-2029) & (M USD)
Table 111. North America Biosimilar Sales Forecast by Country (2024-2029) & (K MT)
Table 112. North America Biosimilar Market Size Forecast by Country (2024-2029) & (M USD)
Table 113. Europe Biosimilar Sales Forecast by Country (2024-2029) & (K MT)
Table 114. Europe Biosimilar Market Size Forecast by Country (2024-2029) & (M USD)
Table 115. Asia Pacific Biosimilar Sales Forecast by Region (2024-2029) & (K MT)
Table 116. Asia Pacific Biosimilar Market Size Forecast by Region (2024-2029) & (M USD)
Table 117. South America Biosimilar Sales Forecast by Country (2024-2029) & (K MT)
Table 118. South America Biosimilar Market Size Forecast by Country (2024-2029) & (M USD)
Table 119. Middle East and Africa Biosimilar Consumption Forecast by Country (2024-2029) & (Units)
Table 120. Middle East and Africa Biosimilar Market Size Forecast by Country (2024-2029) & (M USD)
Table 121. Global Biosimilar Sales Forecast by Type (2024-2029) & (K MT)
Table 122. Global Biosimilar Market Size Forecast by Type (2024-2029) & (M USD)
Table 123. Global Biosimilar Price Forecast by Type (2024-2029) & (USD/MT)
Table 124. Global Biosimilar Sales (K MT) Forecast by Application (2024-2029)
Table 125. Global Biosimilar Market Size Forecast by Application (2024-2029) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Biosimilar Market Size Comparison by Region (M USD)
Table 5. Global Biosimilar Sales (K MT) by Manufacturers (2018-2023)
Table 6. Global Biosimilar Sales Market Share by Manufacturers (2018-2023)
Table 7. Global Biosimilar Revenue (M USD) by Manufacturers (2018-2023)
Table 8. Global Biosimilar Revenue Share by Manufacturers (2018-2023)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biosimilar as of 2022)
Table 10. Global Market Biosimilar Average Price (USD/MT) of Key Manufacturers (2018-2023)
Table 11. Manufacturers Biosimilar Sales Sites and Area Served
Table 12. Manufacturers Biosimilar Product Type
Table 13. Global Biosimilar Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Biosimilar
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Biosimilar Market Challenges
Table 22. Market Restraints
Table 23. Global Biosimilar Sales by Type (K MT)
Table 24. Global Biosimilar Market Size by Type (M USD)
Table 25. Global Biosimilar Sales (K MT) by Type (2018-2023)
Table 26. Global Biosimilar Sales Market Share by Type (2018-2023)
Table 27. Global Biosimilar Market Size (M USD) by Type (2018-2023)
Table 28. Global Biosimilar Market Size Share by Type (2018-2023)
Table 29. Global Biosimilar Price (USD/MT) by Type (2018-2023)
Table 30. Global Biosimilar Sales (K MT) by Application
Table 31. Global Biosimilar Market Size by Application
Table 32. Global Biosimilar Sales by Application (2018-2023) & (K MT)
Table 33. Global Biosimilar Sales Market Share by Application (2018-2023)
Table 34. Global Biosimilar Sales by Application (2018-2023) & (M USD)
Table 35. Global Biosimilar Market Share by Application (2018-2023)
Table 36. Global Biosimilar Sales Growth Rate by Application (2018-2023)
Table 37. Global Biosimilar Sales by Region (2018-2023) & (K MT)
Table 38. Global Biosimilar Sales Market Share by Region (2018-2023)
Table 39. North America Biosimilar Sales by Country (2018-2023) & (K MT)
Table 40. Europe Biosimilar Sales by Country (2018-2023) & (K MT)
Table 41. Asia Pacific Biosimilar Sales by Region (2018-2023) & (K MT)
Table 42. South America Biosimilar Sales by Country (2018-2023) & (K MT)
Table 43. Middle East and Africa Biosimilar Sales by Region (2018-2023) & (K MT)
Table 44. Allergan plc Biosimilar Basic Information
Table 45. Allergan plc Biosimilar Product Overview
Table 46. Allergan plc Biosimilar Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 47. Allergan plc Business Overview
Table 48. Allergan plc Biosimilar SWOT Analysis
Table 49. Allergan plc Recent Developments
Table 50. BIOCAD Biosimilar Basic Information
Table 51. BIOCAD Biosimilar Product Overview
Table 52. BIOCAD Biosimilar Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 53. BIOCAD Business Overview
Table 54. BIOCAD Biosimilar SWOT Analysis
Table 55. BIOCAD Recent Developments
Table 56. Biocon Biosimilar Basic Information
Table 57. Biocon Biosimilar Product Overview
Table 58. Biocon Biosimilar Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 59. Biocon Business Overview
Table 60. Biocon Biosimilar SWOT Analysis
Table 61. Biocon Recent Developments
Table 62. BioXpress Therapeutics Biosimilar Basic Information
Table 63. BioXpress Therapeutics Biosimilar Product Overview
Table 64. BioXpress Therapeutics Biosimilar Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 65. BioXpress Therapeutics Business Overview
Table 66. BioXpress Therapeutics Biosimilar SWOT Analysis
Table 67. BioXpress Therapeutics Recent Developments
Table 68. Boehringer Ingelheim Biosimilar Basic Information
Table 69. Boehringer Ingelheim Biosimilar Product Overview
Table 70. Boehringer Ingelheim Biosimilar Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 71. Boehringer Ingelheim Business Overview
Table 72. Boehringer Ingelheim Biosimilar SWOT Analysis
Table 73. Boehringer Ingelheim Recent Developments
Table 74. Celltrion Biosimilar Basic Information
Table 75. Celltrion Biosimilar Product Overview
Table 76. Celltrion Biosimilar Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 77. Celltrion Business Overview
Table 78. Celltrion Recent Developments
Table 79. Coherus BioSciences Biosimilar Basic Information
Table 80. Coherus BioSciences Biosimilar Product Overview
Table 81. Coherus BioSciences Biosimilar Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 82. Coherus BioSciences Business Overview
Table 83. Coherus BioSciences Recent Developments
Table 84. Dr. Reddy’s Laboratories Biosimilar Basic Information
Table 85. Dr. Reddy’s Laboratories Biosimilar Product Overview
Table 86. Dr. Reddy’s Laboratories Biosimilar Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 87. Dr. Reddy’s Laboratories Business Overview
Table 88. Dr. Reddy’s Laboratories Recent Developments
Table 89. Genor BioPharma Biosimilar Basic Information
Table 90. Genor BioPharma Biosimilar Product Overview
Table 91. Genor BioPharma Biosimilar Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 92. Genor BioPharma Business Overview
Table 93. Genor BioPharma Recent Developments
Table 94. Intas Pharmaceuticals Limited Biosimilar Basic Information
Table 95. Intas Pharmaceuticals Limited Biosimilar Product Overview
Table 96. Intas Pharmaceuticals Limited Biosimilar Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 97. Intas Pharmaceuticals Limited Business Overview
Table 98. Intas Pharmaceuticals Limited Recent Developments
Table 99. Novartis Biosimilar Basic Information
Table 100. Novartis Biosimilar Product Overview
Table 101. Novartis Biosimilar Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 102. Novartis Business Overview
Table 103. Novartis Recent Developments
Table 104. Pfizer Biosimilar Basic Information
Table 105. Pfizer Biosimilar Product Overview
Table 106. Pfizer Biosimilar Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 107. Pfizer Business Overview
Table 108. Pfizer Recent Developments
Table 109. Global Biosimilar Sales Forecast by Region (2024-2029) & (K MT)
Table 110. Global Biosimilar Market Size Forecast by Region (2024-2029) & (M USD)
Table 111. North America Biosimilar Sales Forecast by Country (2024-2029) & (K MT)
Table 112. North America Biosimilar Market Size Forecast by Country (2024-2029) & (M USD)
Table 113. Europe Biosimilar Sales Forecast by Country (2024-2029) & (K MT)
Table 114. Europe Biosimilar Market Size Forecast by Country (2024-2029) & (M USD)
Table 115. Asia Pacific Biosimilar Sales Forecast by Region (2024-2029) & (K MT)
Table 116. Asia Pacific Biosimilar Market Size Forecast by Region (2024-2029) & (M USD)
Table 117. South America Biosimilar Sales Forecast by Country (2024-2029) & (K MT)
Table 118. South America Biosimilar Market Size Forecast by Country (2024-2029) & (M USD)
Table 119. Middle East and Africa Biosimilar Consumption Forecast by Country (2024-2029) & (Units)
Table 120. Middle East and Africa Biosimilar Market Size Forecast by Country (2024-2029) & (M USD)
Table 121. Global Biosimilar Sales Forecast by Type (2024-2029) & (K MT)
Table 122. Global Biosimilar Market Size Forecast by Type (2024-2029) & (M USD)
Table 123. Global Biosimilar Price Forecast by Type (2024-2029) & (USD/MT)
Table 124. Global Biosimilar Sales (K MT) Forecast by Application (2024-2029)
Table 125. Global Biosimilar Market Size Forecast by Application (2024-2029) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Biosimilar
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Biosimilar Market Size (M USD), 2018-2029
Figure 5. Global Biosimilar Market Size (M USD) (2018-2029)
Figure 6. Global Biosimilar Sales (K MT) & (2018-2029)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Biosimilar Market Size by Country (M USD)
Figure 11. Biosimilar Sales Share by Manufacturers in 2022
Figure 12. Global Biosimilar Revenue Share by Manufacturers in 2022
Figure 13. Biosimilar Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 Vs 2022
Figure 14. Global Market Biosimilar Average Price (USD/MT) of Key Manufacturers in 2022
Figure 15. The Global 5 and 10 Largest Players: Market Share by Biosimilar Revenue in 2022
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Biosimilar Market Share by Type
Figure 18. Sales Market Share of Biosimilar by Type (2018-2023)
Figure 19. Sales Market Share of Biosimilar by Type in 2022
Figure 20. Market Size Share of Biosimilar by Type (2018-2023)
Figure 21. Market Size Market Share of Biosimilar by Type in 2022
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Biosimilar Market Share by Application
Figure 24. Global Biosimilar Sales Market Share by Application (2018-2023)
Figure 25. Global Biosimilar Sales Market Share by Application in 2022
Figure 26. Global Biosimilar Market Share by Application (2018-2023)
Figure 27. Global Biosimilar Market Share by Application in 2022
Figure 28. Global Biosimilar Sales Growth Rate by Application (2018-2023)
Figure 29. Global Biosimilar Sales Market Share by Region (2018-2023)
Figure 30. North America Biosimilar Sales and Growth Rate (2018-2023) & (K MT)
Figure 31. North America Biosimilar Sales Market Share by Country in 2022
Figure 32. U.S. Biosimilar Sales and Growth Rate (2018-2023) & (K MT)
Figure 33. Canada Biosimilar Sales (K MT) and Growth Rate (2018-2023)
Figure 34. Mexico Biosimilar Sales (Units) and Growth Rate (2018-2023)
Figure 35. Europe Biosimilar Sales and Growth Rate (2018-2023) & (K MT)
Figure 36. Europe Biosimilar Sales Market Share by Country in 2022
Figure 37. Germany Biosimilar Sales and Growth Rate (2018-2023) & (K MT)
Figure 38. France Biosimilar Sales and Growth Rate (2018-2023) & (K MT)
Figure 39. U.K. Biosimilar Sales and Growth Rate (2018-2023) & (K MT)
Figure 40. Italy Biosimilar Sales and Growth Rate (2018-2023) & (K MT)
Figure 41. Russia Biosimilar Sales and Growth Rate (2018-2023) & (K MT)
Figure 42. Asia Pacific Biosimilar Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Biosimilar Sales Market Share by Region in 2022
Figure 44. China Biosimilar Sales and Growth Rate (2018-2023) & (K MT)
Figure 45. Japan Biosimilar Sales and Growth Rate (2018-2023) & (K MT)
Figure 46. South Korea Biosimilar Sales and Growth Rate (2018-2023) & (K MT)
Figure 47. India Biosimilar Sales and Growth Rate (2018-2023) & (K MT)
Figure 48. Southeast Asia Biosimilar Sales and Growth Rate (2018-2023) & (K MT)
Figure 49. South America Biosimilar Sales and Growth Rate (K MT)
Figure 50. South America Biosimilar Sales Market Share by Country in 2022
Figure 51. Brazil Biosimilar Sales and Growth Rate (2018-2023) & (K MT)
Figure 52. Argentina Biosimilar Sales and Growth Rate (2018-2023) & (K MT)
Figure 53. Columbia Biosimilar Sales and Growth Rate (2018-2023) & (K MT)
Figure 54. Middle East and Africa Biosimilar Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Biosimilar Sales Market Share by Region in 2022
Figure 56. Saudi Arabia Biosimilar Sales and Growth Rate (2018-2023) & (K MT)
Figure 57. UAE Biosimilar Sales and Growth Rate (2018-2023) & (K MT)
Figure 58. Egypt Biosimilar Sales and Growth Rate (2018-2023) & (K MT)
Figure 59. Nigeria Biosimilar Sales and Growth Rate (2018-2023) & (K MT)
Figure 60. South Africa Biosimilar Sales and Growth Rate (2018-2023) & (K MT)
Figure 61. Global Biosimilar Sales Forecast by Volume (2018-2029) & (K MT)
Figure 62. Global Biosimilar Market Size Forecast by Value (2018-2029) & (M USD)
Figure 63. Global Biosimilar Sales Market Share Forecast by Type (2024-2029)
Figure 64. Global Biosimilar Market Share Forecast by Type (2024-2029)
Figure 65. Global Biosimilar Sales Forecast by Application (2024-2029)
Figure 66. Global Biosimilar Market Share Forecast by Application (2024-2029)
Figure 1. Product Picture of Biosimilar
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Biosimilar Market Size (M USD), 2018-2029
Figure 5. Global Biosimilar Market Size (M USD) (2018-2029)
Figure 6. Global Biosimilar Sales (K MT) & (2018-2029)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Biosimilar Market Size by Country (M USD)
Figure 11. Biosimilar Sales Share by Manufacturers in 2022
Figure 12. Global Biosimilar Revenue Share by Manufacturers in 2022
Figure 13. Biosimilar Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 Vs 2022
Figure 14. Global Market Biosimilar Average Price (USD/MT) of Key Manufacturers in 2022
Figure 15. The Global 5 and 10 Largest Players: Market Share by Biosimilar Revenue in 2022
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Biosimilar Market Share by Type
Figure 18. Sales Market Share of Biosimilar by Type (2018-2023)
Figure 19. Sales Market Share of Biosimilar by Type in 2022
Figure 20. Market Size Share of Biosimilar by Type (2018-2023)
Figure 21. Market Size Market Share of Biosimilar by Type in 2022
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Biosimilar Market Share by Application
Figure 24. Global Biosimilar Sales Market Share by Application (2018-2023)
Figure 25. Global Biosimilar Sales Market Share by Application in 2022
Figure 26. Global Biosimilar Market Share by Application (2018-2023)
Figure 27. Global Biosimilar Market Share by Application in 2022
Figure 28. Global Biosimilar Sales Growth Rate by Application (2018-2023)
Figure 29. Global Biosimilar Sales Market Share by Region (2018-2023)
Figure 30. North America Biosimilar Sales and Growth Rate (2018-2023) & (K MT)
Figure 31. North America Biosimilar Sales Market Share by Country in 2022
Figure 32. U.S. Biosimilar Sales and Growth Rate (2018-2023) & (K MT)
Figure 33. Canada Biosimilar Sales (K MT) and Growth Rate (2018-2023)
Figure 34. Mexico Biosimilar Sales (Units) and Growth Rate (2018-2023)
Figure 35. Europe Biosimilar Sales and Growth Rate (2018-2023) & (K MT)
Figure 36. Europe Biosimilar Sales Market Share by Country in 2022
Figure 37. Germany Biosimilar Sales and Growth Rate (2018-2023) & (K MT)
Figure 38. France Biosimilar Sales and Growth Rate (2018-2023) & (K MT)
Figure 39. U.K. Biosimilar Sales and Growth Rate (2018-2023) & (K MT)
Figure 40. Italy Biosimilar Sales and Growth Rate (2018-2023) & (K MT)
Figure 41. Russia Biosimilar Sales and Growth Rate (2018-2023) & (K MT)
Figure 42. Asia Pacific Biosimilar Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Biosimilar Sales Market Share by Region in 2022
Figure 44. China Biosimilar Sales and Growth Rate (2018-2023) & (K MT)
Figure 45. Japan Biosimilar Sales and Growth Rate (2018-2023) & (K MT)
Figure 46. South Korea Biosimilar Sales and Growth Rate (2018-2023) & (K MT)
Figure 47. India Biosimilar Sales and Growth Rate (2018-2023) & (K MT)
Figure 48. Southeast Asia Biosimilar Sales and Growth Rate (2018-2023) & (K MT)
Figure 49. South America Biosimilar Sales and Growth Rate (K MT)
Figure 50. South America Biosimilar Sales Market Share by Country in 2022
Figure 51. Brazil Biosimilar Sales and Growth Rate (2018-2023) & (K MT)
Figure 52. Argentina Biosimilar Sales and Growth Rate (2018-2023) & (K MT)
Figure 53. Columbia Biosimilar Sales and Growth Rate (2018-2023) & (K MT)
Figure 54. Middle East and Africa Biosimilar Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Biosimilar Sales Market Share by Region in 2022
Figure 56. Saudi Arabia Biosimilar Sales and Growth Rate (2018-2023) & (K MT)
Figure 57. UAE Biosimilar Sales and Growth Rate (2018-2023) & (K MT)
Figure 58. Egypt Biosimilar Sales and Growth Rate (2018-2023) & (K MT)
Figure 59. Nigeria Biosimilar Sales and Growth Rate (2018-2023) & (K MT)
Figure 60. South Africa Biosimilar Sales and Growth Rate (2018-2023) & (K MT)
Figure 61. Global Biosimilar Sales Forecast by Volume (2018-2029) & (K MT)
Figure 62. Global Biosimilar Market Size Forecast by Value (2018-2029) & (M USD)
Figure 63. Global Biosimilar Sales Market Share Forecast by Type (2024-2029)
Figure 64. Global Biosimilar Market Share Forecast by Type (2024-2029)
Figure 65. Global Biosimilar Sales Forecast by Application (2024-2029)
Figure 66. Global Biosimilar Market Share Forecast by Application (2024-2029)
